首页> 外国专利> Asenapine for the treatment of schizophrenia in a patient with obesity or obesity

Asenapine for the treatment of schizophrenia in a patient with obesity or obesity

机译:阿塞那平用于治疗肥胖症或肥胖症患者的精神分裂症

摘要

The invention provides means for the treatment of schizophrenia with an antipsychotic agent administered to a patient with overweight, or to a patient that was having weight gain due to an antipsychotic agent, or to a patient that needs to be protected against weight increase due to the presence of risk factors for a disease for which overweight is also a risk factor or due to the presence of other weight increasing factors by using asenapine for the manufacture of a medicine for such treatment.
机译:本发明提供了用抗精神病药治疗精神分裂症的方法,所述抗精神病药施用于超重的患者,或由于抗精神病药而体重增加的患者,或需要保护的患者,以防止由于精神病引起的体重增加通过使用阿塞那平来生产用于这种治疗的药物,对于超重也是危险因素或由于其他体重增加因素的疾病,存在危险因素。

著录项

  • 公开/公告号DK1635820T3

    专利类型

  • 公开/公告日2008-09-08

    原文格式PDF

  • 申请/专利权人 N.V. ORGANON;

    申请/专利号DK20040766041T

  • 发明设计人 TONNAER JEROEN A. D. M;

    申请日2004-06-09

  • 分类号A61K31/407;A61P25/18;

  • 国家 DK

  • 入库时间 2022-08-21 20:08:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号